Ben Tre Pharmaceutical JSC

Ben Tre Pharmaceutical JSC PEG

The PEG Ratio (Price/Earnings-to-Growth) of Ben Tre Pharmaceutical JSC (DBT.VN) as of Oct 30, 2026 is 2.69. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 2.90 — a change of -7.20% (lower).

PEG

2.69

YoY

-7.20%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Ben Tre Pharmaceutical JSC is 2024 2.69 . PEG Ratio (Price/Earnings-to-Growth) of Ben Tre Pharmaceutical JSC was 2023 2.90 . It decreases by -7.20% lower compared to the previous year.

The Ben Tre Pharmaceutical JSC PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2014
4.02 VND
Jan 1, 2015
1.89 VND
Jan 1, 2020
3.88 VND
Jan 1, 2021
3.19 VND
Jan 1, 2022
1.11 VND
Jan 1, 2023
2.90 VND
Jan 1, 2024
2.69 VND
The Ben Tre Pharmaceutical JSC PEG history
YEARPEGYoY
2.69-7.20%
2.90+161.50%
1.11-65.20%
3.19-17.84%
3.88+105.31%
1.89-52.98%
4.02—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ben Tre Pharmaceutical JSC Stock analysis

What does Ben Tre Pharmaceutical JSC do? Ben Tre Pharmaceutical JSC manufactures and distributes pharmaceutical products, including medicinal products through its subsidiaries. The company wholesales, imports, and exports pharmaceuticals, materials, chemicals, packagings, and biological products. It also retails drugs and trades supplements, medical equipment, supplies, and machinery. The firm rents commercial space for additional revenue. Its primary customers are healthcare providers, pharmacies, and medical institutions requiring pharmaceuticals and medical supplies. The company's revenue streams include pharmaceutical manufacturing, wholesale distribution, import/export services, retail drug sales, and commercial space rentals. Key segments are pharmaceuticals, medical equipment, and biological products. The firm serves healthcare sectors through its subsidiaries and direct retail channels. Revenue is generated from both domestic and international trade activities. Ben Tre Pharmaceutical JSC's products include pharmaceuticals, medicinal products, medical equipment, and supplements. The company's brands are not specified in the business description. It targets healthcare providers, pharmacies, and medical institutions as its main buyers. The firm's operations span manufacturing, distribution, retail, and commercial leasing within the pharmaceutical and medical sectors. Ben Tre Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ben Tre Pharmaceutical JSC stock

PEG Ratio (Price/Earnings-to-Growth) of Ben Tre Pharmaceutical JSC is 2.69 in 2024.

PEG Ratio (Price/Earnings-to-Growth) of Ben Tre Pharmaceutical JSC changed from 2.90 to 2.69, representing a -7.20% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Ben Tre Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Ben Tre Pharmaceutical JSC with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Ben Tre Pharmaceutical JSC

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Ben Tre Pharmaceutical JSC